scholarly journals The influence of cosmetic breast augmentation on the stage distribution and prognosis of women subsequently diagnosed with breast cancer

2010 ◽  
pp. NA-NA ◽  
Author(s):  
Lin Xie ◽  
Jacques Brisson ◽  
Eric J. Holowaty ◽  
Paul J. Villeneuve ◽  
Yang Mao
Keyword(s):  
Breast Cancer ◽  
Breast Augmentation ◽  
Stage Distribution

First experience with MRI-guided vacuum aspirated breast biopsy

2020 ◽  
pp. 25-31
Author(s):  
M. L. Mazo ◽  
O. E. Jacobs ◽  
O. S. Puchkova ◽  
M. V. Feldsherov ◽  
E. V. Kondratyev
Keyword(s):  
Breast Cancer ◽  
Breast Augmentation ◽  
Breast Biopsy ◽  
Breast Mri ◽  
Breast Tumors ◽  
High Tech ◽  
X Ray ◽  
Vacuum Aspiration ◽  
Mri Guided ◽  
Aesthetic Breast

The rate of detection of breast cancer by MRI, while other methods of radiological diagnosis are not sufficiently informative, ranges from 5.2 to 26.3 per cent. Suspicious breast tumors of category BI-RADS 4, 5 show morphological image-guided biopsy verification, in particular MRI with contrast. Purpose. To show the possibilities and features of carrying out MRI-guided vacuum breast biopsy, including after aesthetic breast augmentation. Material and methods. A comprehensive X-ray, ultrasound and MRI examination of 54 women aged between 28 and 70 years with different breast tumors was conducted. Of these, five were detected only by breast MRI with contrast, and were morphologically verified by MRI-guided vacuum aspiration biopsy. Results. 14 of the 54 patients with breast mass were diagnosed with breast cancer and 26 were diagnosed with benign diseases. The effectiveness of comprehensive examination and low-invasive high-tech MRI-guided procedures in early refined screening for breast cancer, including after aesthetic breast augmentation, has been demonstrated. MRI-guided vacuum-assisted breast biopsy is a fast, safe and accurate diagnostic method of morphological verification of suspicious breast tumors that do not have X-ray and ultrasound.

Targeted breast surgery: Non-direct approach.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e12602-e12602
Author(s):  
Peter Kern ◽  
Alina Kessel ◽  
Oliver Hoffmann ◽  
Ann-Kathrin Bittner ◽  
Rainer Kimmig
Keyword(s):  
Breast Cancer ◽  
Mammary Gland ◽  
Neoadjuvant Chemotherapy ◽  
Breast Surgery ◽  
Intraoperative Ultrasound ◽  
Direct Approach ◽  
Aesthetic Result ◽  
Stage Distribution ◽  
Tumor Stages ◽  
Patient Reported

e12602 Background: Breast conserving surgery is the standard in T1-T3 primary breast cancer. The cosmetic result is very much depending upon the surgeon ́s experience, the tumor-size/breast ratio and the technique applied. We have proposed a nomogram earlier (1) which has been cited earlier by the American Society of Breast Surgeons Consensus Conference as a concept for avoidance of re-excisions and achievement of a favorable aesthetic result. Our nomogram proposed 5 simple oncoplastic techniques to handle the vast majority of breast cancer cases, with high rates of free margins. However, these techniques all used direct access to the mammary gland through the skin above the tumor, leaving permanent scars in the visible skin of the breast. To avoid this, we now have chosen a more natural access to the mammary gland along natural transitions and Langerhans´s skin lines in this prospective open-label study. Methods: We conducted a prospective open-arm study including all primary invasive and non-invasive breast cancer cases of tumor stages AJCC 0-III A (Version 8.0). Non-palbable tumors and those undergoing neoadjuvant chemotherapy had to be marked by a wire and clipped before. Intraoperative ultrasound was applied before skin incision and after removal of the tumor including ultrasound of the specimen to confirm clear margins). Resection was performed as a segmentectomy and SLN biopsy and axillary clearance was done according to national guidelines. Access to the tumor was chosen in a non-direct approach according to the proximity of the tumor to one of the following natural transitions: 1. areola 2. axillary line 3. inframammary fold. Results: 84 patients with breast conserving targeted breast surgery with a "non-direct to the tumor approach" have been enrolled so far. 76 patients had primary surgery with stage distribution as follows: Tis (1), T1a (3), T1b (8), T1c (30), T2 (30), T3 (4) and T4b(1). 8 patients had neoadjuvant chemotherapy with stage distribution as follows: ypT0 (3), ypT1a (2), ypT1c (1) and ypT2 (2). Histopathology was predominantly invasive-ductal breast cancer (70), followed by invasive-lobular (6), ductulo-lobular (5), invasive- ductal and pure DCIS (1), invasive-ductal and mucinous (1) and mucinous only (1). After first surgery according to our nomogram 77 patients had a tumor resection with free margins and 7 with involved margins, thus 91,6 % tumors were resected with free margins at first surgery. The remaining 8,4 % of cases were margin-free after second surgery. Conclusions: Scars were not visible on the surface of the breast outside of natural transitions and rate of free margins was high with targeted breast surgery at a rate of 91,6 % without any cosmetic impairment due to the remote natural access to the mammary gland. Patient-reported outcome in detail has been evaluated by validated questionnaires and demonstrated a high satisfaction with scar pattern, volume and symmetry.

The impact of the COVID-19 pandemic on stage at diagnosis of breast and colorectal cancers.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. 6501-6501
Author(s):  
Jade Zhou ◽  
Shelly Kane ◽  
Celia Ramsey ◽  
Melody Ann Akhondzadeh ◽  
Ananya Banerjee ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Colorectal Cancer ◽  
Cancer Screening ◽  
Late Stage ◽  
Stage Iv ◽  
Stage I ◽  
Screening Programs ◽  
Stage Distribution ◽  
Number Of Patients ◽  
The Impact

6501 Background: Effective cancer screening leads to a substantial increase in the detection of earlier stages of cancer, while decreasing the incidence of later stage cancer diagnoses. Timely screening programs are critical in reducing cancer-related mortality in both breast and colorectal cancer by detecting tumors at an early, curable stage. The COVID-19 pandemic resulted in the postponement or cancellation of many screening procedures, due to both patient fears of exposures within the healthcare system as well as the cancellation of some elective procedures. We sought to identify how the COVID-19 pandemic has impacted the incidence of early and late stage breast and colorectal cancer diagnoses at our institution. Methods: We examined staging for all patients presenting to UCSD at first presentation for a new diagnosis of malignancy or second opinion in 2019 and 2020. Treating clinicians determined the stage at presentation for all patients using an AJCC staging module (8th edition) in the electronic medical record (Epic). We compared stage distribution at presentation in 2019 vs 2020, both for cancers overall and for colorectal and breast cancer, because these cancers are frequently detected by screening. Results: Total numbers of new patient visits for malignancy were similar in 2019 and 2020 (1894 vs 1915 pts), and stage distribution for all cancer patients was similar (stage I 32% in 2019 vs 29% in 2020; stage IV 26% in both 2019 and 2020). For patients with breast cancer, we saw a lower number of patients presenting with stage I disease (64% in 2019 vs 51% in 2020) and a higher number presenting with stage IV (2% vs 6%). Similar findings were seen in colorectal cancer (stage I: 22% vs 16%; stage IV: 6% vs 18%). Conclusions: Since the COVID-19 pandemic, there has been an increase in incidence of late stage presentation of colorectal and breast cancer, corresponding with a decrease in early stage presentation of these cancers at our institution. Cancer screening is integral to cancer prevention and control, specifically in colorectal and breast cancers which are often detected by screening, and the disruption of screening services has had a significant impact on our patients. We plan to continue following these numbers closely, and will present data from the first half of 2021 as it becomes available.

Contrast-Enhanced Mammography for Newly Diagnosed Breast Cancer in Women With Breast Augmentation: Preliminary Findings

2021 ◽  
Author(s):  
Molly Carnahan ◽  
Barbara Pockaj ◽  
Victor Pizzitola ◽  
Marina Giurescu ◽  
Roxanne Lorans ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Augmentation ◽  
Newly Diagnosed ◽  
Contrast Enhanced

Review of Methods in “Breast Augmentation: A Risk Factor for Breast Cancer?”

1994 ◽  
Vol 330 (4) ◽  
pp. 293-293 ◽  
Author(s):  
Heather Bryant ◽  
Penny M.A. Brasher ◽  
Johan H. van de Sande ◽  
Jean-Michel Turc
Keyword(s):  
Breast Cancer ◽  
Risk Factor ◽  
Breast Augmentation

scholarly journals A Case of Breast Cancer Complicated with Silicone Granuloma after Breast Augmentation

2019 ◽  
Vol 80 (5) ◽  
pp. 842-847
Author(s):  
Mariko OYA ◽  
Toshihisa OGAWA ◽  
Ei-ichi TSUJI ◽  
Noriaki HAYASHIBARA ◽  
Akiko FUJII
Keyword(s):  
Breast Cancer ◽  
Breast Augmentation ◽  
Silicone Granuloma

Diagnosis of breast cancer at dynamic MRI in patients with breast augmentation by paraffin or silicone injection

2009 ◽  
Vol 64 (12) ◽  
pp. 1175-1180 ◽  
Author(s):  
J.H. Youk ◽  
E.J. Son ◽  
E.-K. Kim ◽  
J.-A. Kim ◽  
M.J. Kim ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Augmentation ◽  
Dynamic Mri ◽  
Silicone Injection

scholarly journals A case of breast cancer following collagen injection for breast augmentation

2012 ◽  
Vol 73 (10) ◽  
pp. 2504-2508
Author(s):  
Shigenori NAGAKURA ◽  
Hidenaka KOKAI ◽  
Hideya TAKAKU ◽  
Haruna OIKAWA ◽  
Nobuhiro KASUGA ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Augmentation ◽  
Collagen Injection
Sign in / Sign up

Export Citation Format

Share Document